Status:
COMPLETED
Endovascular Thrombectomy in COVID-19 Infected Patients
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Ischemic Stroke
Covid 19
Eligibility:
All Genders
18+ years
Brief Summary
About 5% of COVID-19 patients may present symptoms related to acute ischemic stroke (AIS). Treatment-management and outcomes related to mechanical thrombectomy (MT) for COVID-19 infected patients harb...
Detailed Description
Since the identification of the first case of Severe Acute Respiratory Syndrome (SARS) CoV-2 infection in December 2019 in Wuhan, China, the global number of confirmed COVID-19 cases is roughly 5 000 ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patients \>18 years infected with the SARR-CoV-2 with acute ischemic stroke, and eligible for mechanical thrombectomy (based on the current guide-lines)
- Exclusion criteria:
- \- Patients \<18 years ; no eligibility to mechanical thrombectomy ; absence of diagnosis of COVID-19
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04406090
Start Date
April 1 2020
End Date
June 30 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295